Emblem Corp (OTC:EMMBF) CEO Nick Dean tells Proactive Investors that the company plans to export to markets beyond Canada once construction is complete on its new "integrated" building. The space combines extraction, analytical, cannabis storage, R&D, and production activities.
Dean says the company is also focused on the recreational market in Canada.
Meet ANGLE plc, Faron Pharmaceuticals Ltd, Alliance Pharma plc, Clinigen Group PLC and Avacta Group Plc at our event,
London , 05 April 2018.
Register here »
Bagikan Berita Ini
0 Response to "Emblem Corp creating "integrated building" to manufacture & produce medical products"
Post a Comment